LADFX
Price
$26.85
Change
-$0.21 (-0.78%)
Updated
Sep 25 closing price
Net Assets
2.07B
VEXRX
Price
$111.02
Change
-$0.98 (-0.88%)
Updated
Sep 25 closing price
Net Assets
20.46B
Interact to see
Advertisement

LADFX vs VEXRX

Header iconLADFX vs VEXRX Comparison
Open Charts LADFX vs VEXRXBanner chart's image
Lord Abbett Developing Growth F
Price$26.85
Change-$0.21 (-0.78%)
VolumeN/A
Net Assets2.07B
Vanguard Explorer Adm
Price$111.02
Change-$0.98 (-0.88%)
VolumeN/A
Net Assets20.46B
LADFX vs VEXRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LADFX vs. VEXRX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LADFX is a Hold and VEXRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.5B vs. LADFX (2.07B). VEXRX pays higher dividends than LADFX: VEXRX (0.50) vs LADFX (0.12). LADFX was incepted earlier than VEXRX: LADFX (18 years) vs VEXRX (24 years). LADFX (0.79) is less costly to investors than VEXRX (0.33). LADFX is a more actively managed with annual turnover of: 122.00 vs. VEXRX (35.00). LADFX has a lower initial minimum investment than VEXRX: LADFX (0) vs VEXRX (50000). LADFX annual gain was more profitable for investors over the last year : 12.89 vs. VEXRX (-0.58). VEXRX return over 5 years is better than : 14.06 vs. LADFX (-1.23).
LADFXVEXRXLADFX / VEXRX
Total Expense Ratio0.790.33239%
Annual Report Gross Expense Ratio0.790.33239%
Fund Existence18 years24 years-
Gain YTD11.2664.820234%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.07B20.5B10%
Annual Yield % from dividends0.120.5025%
Returns for 1 year12.89-0.58-2,220%
Returns for 3 years51.5332.61158%
Returns for 5 years-1.2314.06-9%
Returns for 10 years29.8241.7871%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNHIX26.88N/A
N/A
Manning & Napier Pro-Blend Max Term I
BLRAX11.82N/A
N/A
Brookfield Global Listed Real Estate A
PHLQX43.70N/A
N/A
PGIM Jennison Health Sciences R6
RREMX16.54N/A
N/A
RBC Emerging Markets Equity R6
CIQRX13.38N/A
N/A
Segall Bryant & Hamll Intl Eq Retl